Placement Pending
Adial Pharmaceuticals placement
US$32m raised
Announced 11 Jun 2026 · NASDAQ: ADIL · US$2.75 cash per share
Advisers
Lead managers
- Placement agent
- Issuer
- Adial Pharmaceuticals
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Odyssey Therapeutics placement May 2026 · US$25m · Biotech
- Ensysce Biosciences placement Aug 2026 · US$43m · Biotech
- Skye Bioscience placement Aug 2026 · US$68m · Biotech
- Parabilis Medicines placement Jun 2026 · US$75m · Biotech
- ADARx Pharmaceuticals placement Sep 2026 · US$89m · Biotech
Sources
- 11 Jun 2026 Press release (EX-99.1, exhibit), Adial Pharmaceuticals Announces Acquisition sec.gov